Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH)

Experimental and Molecular Pathology

Volumn 99, Issue 1, 2015, Pages 155-162

  Jindal, Aastha ^a   Bruzzì, Stefania ^a   Sutti, Salvatore ^a   Locatelli, Irene ^a   Bozzola, Cristina ^a   Paternostro, Claudia ^b   Parola, Maurizio ^b   Albano, Emanuele ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Annexin A1; Liver inflammation; Macrophages; Nonalcoholic fatty liver disease

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; LIPOCORTIN 1; LIPOCORTIN 5; TUMOR NECROSIS FACTOR ALPHA; ALANINE AMINOTRANSFERASE; ARG1 PROTEIN, MOUSE; ARGINASE; CXCL10 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; LLGL1 PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; NOS2 PROTEIN, MOUSE; TRIACYLGLYCEROL; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL POLARITY; CELL SIZE; CELL VACUOLE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LIPID VESICLE; LIVER BIOPSY; LIVER CELL; MACROPHAGE ACTIVATION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PROTEIN EXPRESSION; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; CYTOLOGY; DIET; FIBROSIS; IMMUNOLOGY; INFLAMMATION; LIVER; MACROPHAGE; METABOLISM; MONOCYTE; PATHOLOGY;

MUS;

ALANINE TRANSAMINASE; ANIMALS; ANNEXIN A1; ANTIGENS, CD11B; ANTIGENS, LY; ARGINASE; CHEMOKINE CXCL10; DIET; DISEASE PROGRESSION; FIBROSIS; HOMEODOMAIN PROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-12; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE II; NON-ALCOHOLIC FATTY LIVER DISEASE; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 84934292673     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.06.015     Document Type: Article

References (32)

1. Ariel A., Timor O. Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis. J. Pathol. 2013, 229:250-263.
2. Baeck C., Wehr A., Karlmark K.R., et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012, 61:416-426.
3. Caballero T., Gila A., Sánchez-Salgado G., et al. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients. Histol. Histopathol. 2012, 27:459-466.
4. Cooray S.N., Gobbetti T., Montero-Melendez T., et al. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines pro-resolving functional responses. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:18232-18237.
5. Crispe N.I. Isolation of mouse intrahepatic lymphocytes. Current Protocols in Immunology 1997, (3.21.1-321.8).
6. Froh M., Konno A., Thurman R.G. Isolation of Kupffer cells. Curr. Protoc. Toxicol. 2003, (14.4.1-14.4.12)http://dx.doi.org/10.1002/0471140856.tx1404s14.
7. Gentile C.L., Frye M., Pagliasotti M.J. Endoplasmic reticulum stress and unfolded protein response in nonalcoholic fatty liver disease. Antioxid. Redox Signal. 2011, 15:505-521.
8. Ioannou G.N., Haigh W.G., Thorning D., et al. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J. Lipid Res. 2013, 54:1326-1334.
9. Ioannou G.N., Van Rooyen D.M., Savard C., et al. Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH. J. Lipid Res. 2015, 56:277-285.
10. Itoh M., Kato H., Suganami T., et al. Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. PLoS One 2013, 8:e82163. 10.1371/journal.pone.0082163.
11. Leamy A.K., Egnatchik R.A., Young J.D. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog. Lipid Res. 2013, 52:165-174.
12. Leitinger N., Schulman I.G. Phenotypic polarization of macrophages in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1120-1126.
13. Leroux A., Ferrere G., Godie V., et al. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J. Hepatol. 2012, 57:141-149.
14. Locatelli I., Sutti S., Jindal A., et al. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. Hepatology 2014, 60:531-544.
15. Maina V., Sutti S., Locatelli I., et al. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. Clin. Sci. (Lond.) 2012, 122:545-553.
16. McNelis J.C., Olefsky J.M. Macrophages, immunity, and metabolic disease. Immunity 2014, 41(1):36-48. (Jul 17).
17. Miura K., Yang L., van Rooijen N., et al. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G1310-G1321.
18. Moschen A.R., Wieser V., Tilg H. Adiponectin: key player in the adipose tissue-liver crosstalk. Curr. Med. Chem. 2012, 19:5467-5473.
19. Murray P.J., Wynn T.A. Protective and pathogenetic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
20. Ortega-Gómez A., Perretti M., Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol. Med. 2013, 5:661-674.
21. Perretti M., D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 2009, 9:62-70.
22. Prieur X., Mok C.Y., Velagapudi V.R., et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 2011, 60:797-809.
23. Rensen S.S., Slaats Y., Nijhuis J., et al. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am. J. Pathol. 2009, 175:1473-1482.
24. Shapiro H., Pecht T., Shaco-Levy R., et al. Adipose tissue foam cells are present in human obesity. J. Clin. Endocrinol. Metab. 2013, 98:1173-1181.
25. Sutti S., Jindal A., Locatelli I., et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 2014, 59:886-897.
26. Tacke F., Zimmermann H.W. Macrophage heterogeneity in liver injury and fibrosis. J. Hepatol. 2014, 60:1090-1096.
27. Tosello-Trampont A.C., Landes S.G., Nguyen V., et al. Kupffer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J. Biol. Chem. 2012, 287:40161-40172.
28. Wan J., Benkdane M., Teixeira-Clerc F., et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 2014, 59:130-142.
29. Wehr A., Baeck C., Heymann F., et al. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis. J. Immunol. 2013, 190:5226-5236.
30. Yeh M.M., Brunt E.M. Pathological features of fatty liver disease. Gastroenterology 2014, 147:754-764.
31. Zigmond E., Samia-Grinberg S., Pasmanik-Chor M., et al. Infiltrating monocyte-derived macrophages and resident Kupffer cells display different ontogeny and functions in acute liver injury. J. Immunol. 2014, 193:344-353.
32. Zimmermann H.W., Trautwein C., Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front. Physiol. 2012, 3. 10.3389/fphys.2012.00056.